Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10716782
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted -
US 10716869
Radiolabeled macrocyclic EGFR inhibitor
granted -
US 10709705
Aminopyrimidines as ALK inhibitors
granted -
US 10709692
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)
granted -
US 10709758
Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin
granted -
US 10711007
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 10702473
Liposome formulation for delivery of Wnt signal pathway inhibitor
granted -
US 10703746
Mutant IDH1 inhibitors useful for treating cancer
granted -
US 10702506
Small molecule inhibitors of pendrin ion exchange and pharmaceutical compositions
granted -
US 10696693
Fused imidazole derivatives as TGF-beta inhibitors
granted -
EP 3668502
MAKROCYCLISCHE MCL-1-INHIBITOREN UND VERFAHREN ZUR VERWENDUNG
granted -
US 10689397
ULK1 inhibitors and methods using same
granted -
US 10689400
Macrocycle kinase inhibitors
granted -
US 10689357
N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof
granted -
US 10689377
KRas G12C inhibitors
granted -
US 10689347
Substituted heterocyclyl derivatives as CDK inhibitors
granted -
US 10689346
Human plasma kallikrein inhibitors
granted -
US 10683279
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 10683272
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
granted -
AU 2018379646
Dopamine-B-hydroxylase inhibitors
granted -
US 10676486
Macrocyclic RIP2 kinase inhibitors
granted -
US 10676474
1,6-naphthyridine derivatives as CDK4/6 inhibitor
granted -
US 10669242
Clostridium difficile toxin inhibitors
granted -
US 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted